Abstract:
The Wnt/β-catenin signaling pathway is an evolutionary conserved pathway which has important functions in vertebrate early development, axis formation, cellular proliferation and morphogenesis. The activation of this pathway leads to translocation of the transcriptional activator β-catenin into the nucleus where it activates T-cell factor/Lymphoid enhancer factor (Tcf/Lef) family of transcription factors, which regulate expression of developmental and cell cycle-related genes. The results of SAGE (Serial Analysis of Gene Expression) performed recently in our lab indicated that BRI3 (Brain Protein I3) is one of the genes displaying increased expression in the presence of mutant -and thus more stable- form of β-catenin. In previous studies, BRI3 expression was found to be upregulated in Huh7 cell lines upon lithium treatment. Moreover, with regard to previous literature, BRI3 was found to have a very important role in the TNF-α mediated cell death pathway. Also, its promoter activity was analyzed by luciferase reporter assays and found to have been increased due to overexpression of β-catenin. In this study, we screened a human liver cDNA library by yeast two-hybrid assay using BRI3 as bait, with the aim to find novel binding partners of BRI3 and provide clues for the functional study of BRI3 with respect to the Wnt/β-catenin pathway. Library screening by yeast mating resulted in the identification of 2 candidate positive clones, which have been confirmed by cotransformation to the competent yeast cells, but the results still need to be verified by co-immunoprecipitation using mammalian cells. In conclusion, this study mainly will lead to the discovery of novel BRI3-interacting proteins which is essential for identification of the action mechanism of BRI3 in Wnt/β-catenin signaling. Furthermore, any possible interaction between Wnt/β-catenin pathway and TNF-α mediated cell death pathway can be revealed ultimately.
